| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/19/2012 | WO2012007560A1 Use of a cationic amphiphilic drug for the preparation of a formulation for the reduction of subcutaneous adipose tissue |
| 01/19/2012 | WO2012007455A1 Process for the preparation of organic salts |
| 01/19/2012 | WO2012007367A1 New azacyclic compounds |
| 01/19/2012 | WO2012006958A1 Amids substituted indazole derivativees as ploy(adp-ribose)polymerase inhibitors |
| 01/19/2012 | WO2012006956A1 Insulin-lipid complex, preparation method therefor, and preparation thereof |
| 01/19/2012 | WO2012006955A1 Compounds for treatment of metabolic disorders |
| 01/19/2012 | WO2011137160A3 Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans |
| 01/19/2012 | WO2011136469A3 Pharmaceutical composition using connective tissue growth factor |
| 01/19/2012 | WO2011112822A3 Implantable therapeutic device and methods of making |
| 01/19/2012 | WO2011103123A3 Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities |
| 01/19/2012 | WO2011102690A3 Pharmaceutical composition for treating diabetes containing quamoclit angulata extracts |
| 01/19/2012 | US20120016289 Articles, compositions, and methods for killing or preventing the growth of microbes |
| 01/19/2012 | US20120016123 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/19/2012 | US20120016035 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/19/2012 | US20120016016 Methods and compositions for treating complications of diabetes and vascular diseases using flavones |
| 01/19/2012 | US20120016009 Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene |
| 01/19/2012 | US20120016000 Method to assay phospholipid and triglyceride transfer activity of microsomal triglyceride transfer protein |
| 01/19/2012 | US20120015998 Phototherapy methods and devices comprising emissive aryl-heteroaryl compounds |
| 01/19/2012 | US20120015985 Methods of Administering Pirfenidone Therapy |
| 01/19/2012 | US20120015983 Synthesis and Novel Salt Forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine |
| 01/19/2012 | US20120015982 Thiazolidinedione analogues |
| 01/19/2012 | US20120015979 Compounds for Modulating TRPV3 Function |
| 01/19/2012 | US20120015970 New azacyclic compounds |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015958 1-(4-ureidobenzoyl)piperazine derivatives |
| 01/19/2012 | US20120015957 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 01/19/2012 | US20120015952 Inhibitors of NF-KB |
| 01/19/2012 | US20120015938 1,4-benzodiazepin-2-on derivatives |
| 01/19/2012 | US20120015936 Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs |
| 01/19/2012 | US20120015933 Spirocyclic nitriles as protease inhibitors |
| 01/19/2012 | US20120015931 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015926 Compounds for the treatment of inflammatory disorders |
| 01/19/2012 | US20120015925 Novel benzothiazepine and benzothiepine compounds |
| 01/19/2012 | US20120015918 Lipolytic Methods for Regional Adiposity |
| 01/19/2012 | US20120015915 Formulations of 14-epi-analogues of vitamin d |
| 01/19/2012 | US20120015914 Formulations of 14-epi-analogues of vitamin d |
| 01/19/2012 | US20120015913 Formulations of 14-EPI-Analogues of Vitamin D |
| 01/19/2012 | US20120015911 Method and compositions for treating amyloid-related diseases |
| 01/19/2012 | US20120015909 Mao-b inhibitors useful for treating obesity |
| 01/19/2012 | US20120015905 Compounds for the prevention and treatment of cardiovascular diseases |
| 01/19/2012 | US20120015895 Use Of RR/SR-Ractopamine |
| 01/19/2012 | US20120015880 Intranasal desmopressin administration |
| 01/19/2012 | US20120015876 Conjugates of glp-1 agonists and uses thereof |
| 01/19/2012 | US20120015875 Use Of Oxandrolone In The Treatment Of Burns And Other Wounds |
| 01/19/2012 | US20120015868 Metastin derivatives and use thereof |
| 01/19/2012 | US20120015060 Compositions comprising a lipophilic extract of zingiber officinale and an extract of cynara scolymus, which are useful for the prevention and treatment of oesophageal reflux and irritable bowel syndrome |
| 01/19/2012 | US20120015057 Polyphenol composition |
| 01/19/2012 | US20120015046 Methods and kits for co-administration of nutritional supplements |
| 01/19/2012 | US20120015039 Sustained release of nutrients in vivo |
| 01/19/2012 | US20120015038 Enterically coated cysteamine, cystamine and derivatives thereof |
| 01/19/2012 | US20120015029 Direct compression formulation and process |
| 01/19/2012 | US20120015021 Anti-appetite adhesive compositions |
| 01/19/2012 | US20120015014 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 01/19/2012 | US20120014999 Diketopiperazine Microparticles with Defined Specific Surface Areas |
| 01/19/2012 | US20120014989 PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS |
| 01/19/2012 | US20120014979 Use of bcl6 inhibitors for treating autoimmune diseases |
| 01/19/2012 | US20120014951 Pcsk9 antagonists |
| 01/19/2012 | US20120014932 Methods for treating disorders of amino acid metabolism |
| 01/19/2012 | US20120014923 Hypoglycemic effect enhancer |
| 01/19/2012 | US20120014908 Terminally-functionalized conjugates and uses thereof |
| 01/19/2012 | US20120014907 Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 01/19/2012 | US20120014906 Organic compounds |
| 01/19/2012 | US20120014884 Menthol-derivative compounds and use thereof as oral and systemic active agents |
| 01/19/2012 | US20120012499 Tablet formulation |
| 01/19/2012 | CA2805325A1 Insulin-lipid complex, preparation method therefor, and preparation thereof |
| 01/19/2012 | CA2804970A1 Spirocyclic compounds |
| 01/19/2012 | CA2804278A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| 01/19/2012 | CA2802528A1 New azacyclic compounds |
| 01/18/2012 | EP2407486A1 Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 01/18/2012 | EP2407475A2 Synthetic Bile Acid Composition, Method, and Preparation |
| 01/18/2012 | EP2407474A1 Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat |
| 01/18/2012 | EP2407473A2 Method for producing phosphorus-containing compounds |
| 01/18/2012 | EP2407469A1 Salt of sitagliptin |
| 01/18/2012 | EP2407466A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/18/2012 | EP2407174A1 Progression inhibitor or prophylactic agent for atherosclerosis, blood cholesterol level-lowering agent, and functional food or food for specified health uses |
| 01/18/2012 | EP2407168A1 Use of dpp iv inhibitors |
| 01/18/2012 | EP2407153A1 Preparation method of carotenoid oil suspensions with low viscosity and high fluidity and its use |
| 01/18/2012 | EP2407034A1 Particles |
| 01/18/2012 | EP2406266A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| 01/18/2012 | EP2406256A1 Compounds for the treatment of metabolic disorders |
| 01/18/2012 | EP2406253A1 Benzofuranyl derivatives used as glucokinase inhibitors |
| 01/18/2012 | EP2406252A1 Mineralocorticoid receptor antagonist and methods of use |
| 01/18/2012 | EP2406251A1 Compounds for the treatment of metabolic disorders |
| 01/18/2012 | EP2406248A1 Novel isoindolin-1-one derivative |
| 01/18/2012 | EP2406247A1 Compounds for the treatment of metabolic disorders |
| 01/18/2012 | EP2406236A1 Rho kinase inhibitors |
| 01/18/2012 | EP2405972A1 Use of rosuvastatin lactols as medicaments |
| 01/18/2012 | EP2405934A1 Treatment of diabetes and metabolic syndrome |
| 01/18/2012 | EP2405924A1 Plasma-adapted full electrolyte solution |
| 01/18/2012 | EP2405922A1 Nutritional composition inducing a postprandial endocrine response |
| 01/18/2012 | EP2405921A1 Compositions and methods for silencing apolipoprotein c-iii expression |
| 01/18/2012 | EP2405913A1 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
| 01/18/2012 | EP2405911A1 Use of atorvastatin lactols as medicaments |
| 01/18/2012 | EP2405910A1 Rosuvastatin and atorvastatin derivatives |
| 01/18/2012 | EP2405755A1 Methods and compositions for the treatment of metabolic and cardiovascular disorders |
| 01/18/2012 | EP1826197B1 Aminocarboxylic acid derivative and medicinal use thereof |
| 01/18/2012 | EP1637539B1 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 01/18/2012 | EP1575671B1 Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |